Cancer Risk

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.

Usage of combined oral contraceptives to manage PMS and PMDD symptoms, surgical abortion pain management for patients with opioid use disorder, risks associated with post-placental IUD placement, and more.

In-clinic vs pharmacy provision of medication abortion, cost barriers to contraceptive access among community college students, opportunities for PrEP counseling for adolescent and young adults, and more.

The benefit of ultrasound guidance in IUD placement for patients with retroverted uteri, a demonstrated need for trauma-informed care in sexually-transmitted disease clinics, demand among abortion patients for more autonomous care options, and more.

An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.